Document is current
Any future updates will be listed below
-
Authors
Quintana, D S
Westlye, L T
Hope, S
Nærland, T
Elvsåshagen, T
Dørum, E
Rustan, Ø
Valstad, M
Rezvaya, L
Lishaugen, H
Stensønes, E
Yaqub, S
Smerud, K T
Mahmoud, R A
Djupesland, P G
Andreassen, O A
- License Information
-
More Information
Article History
Received: 20 March 2017
Accepted: 28 March 2017
First Online: 23 May 2017
Competing interests
: PGD is an employee of OptiNose AS, Oslo, Norway and owns stock and stock options in OptiNose. RAM is an employee of OptiNose US, Yardley, PA, USA and owns stock and stock options in OptiNose. OAA has received speaker’s honoraria from GSK, Lundbeck and Otsuka for work not directly relevant to the submitted manuscript. KTS is employed by Smerud Medical Research International AS, a CRO receiving fees for clinical trial services from OptiNose AS. The remaining authors declare no conflict of interest.
